Open navigation
Search
Associate

Volodymyr Omelchenko

Kyiv, Ukraine
Languages
  • English
  • Ukrainian
  • French
Social media

Volodymyr Omelchenko is an associate in the Life Sciences & Healthcare team at CMS Ukraine. Volodymyr has over nine years of experience advising multinational and local companies on a broad range of legal issues relating to their business operations in Ukraine. His expertise includes regulatory and compliance matters, data protection, intellectual property, commercial and competition law. 

Volodymyr has a proven track record in advising on complex legal matters and supporting the day-to-day business operations of pharmaceutical, animal health, and medical devices companies. Volodymyr often assists clients with diverse business activities, including conducting legal due diligence, drafting and negotiating contracts, reviewing advertising and promotional materials for compliance, developing internal operating policies and procedures, and advising on a wide range of other legal and regulatory matters.

Relevant experience

  • Roche, a Swiss multinational healthcare holding company, on regulatory, compliance, and competition aspects of regional access and patient support programmes for innovative therapies, ensuring alignment with local laws and competitive standards to support effective healthcare delivery
  • A global leading innovative biopharmaceutical company on regulatory and competition law aspects of transferring marketing authorisations for medicines to a third party
  • The Ukrainian subsidiary of a global pharmaceutical company on competition, commercial and regulatory aspects of the patient support programme, supporting the Client at all stages of the implementation of the project, from a comprehensive assessment of possible legal risks and development of options for their mitigation, to assistance with developing documents for the implementation of the programme.
  • The major international life sciences companies tailored training sessions on the recent and upcoming regulations of pricing, retroactive price revisions, marketing services, restrictions on sales to a single entity and competition law implications of these regulatory developments
  • A UK-based global biopharmaceutical company on the competitive, commercial, regulatory and compliance aspects of implementing nationwide patient support programme, ensuring the programme complied with local regulations, maintained competitive integrity, and effectively supported patients across the country
  • A global innovative pharmaceutical company on preparing and submitting a response to an inquiry by the Antimonopoly Committee of Ukraine
  • A leading international pharmaceutical company on the regulation of prices and mark-ups for medicinal products in Ukraine
  • A global medical devices company on Ukrainian regulatory requirements for the promotion of medical devices
  • A leading international pharmaceutical company on the transformation of the access model to innovative therapies
  • One of the world’s leading research-driven pharmaceutical companies on preparing customer selection and commercial policies, and on compliance with competition law requirements in the context of collaboration with local wholesale distributors
  • A large group of leading pharmaceutical companies in large anti-counterfeiting investigations in Ukraine involving the clients’ counterfeit and illicitly traded drugs
  • An American multinational biopharmaceutical company on compliance with Ukrainian data privacy law in the context of clinical trials conducted in Ukraine
  • A leading global cannabis and life sciences company on challenging the unlawful use of its name and intellectual property on a website
  • A global pharmaceutical company on a broad range of commercial, competition and regulatory matters related to the proposed change of its business model in Ukraine
  • A major US-based pharmaceutical company on complex regulatory matters related to the transfer of the Marketing Authorisation Holder role and delegation of MAH functions in Ukraine
  • A leading international animal health company on the new veterinary legislation in Ukraine and regulatory requirements applicable to veterinary medicinal products

Memberships & Roles

  • American Chamber of Commerce in Ukraine
  • European Business Association

Education

2020 – LL.M, Institute of International Relations Taras Shevchenko National University of Kyiv, Kyiv

2018 – LL.B, Institute of International Relations Taras Shevchenko National University of Kyiv, Kyiv

Practice Areas
Intellectual Property Public Procurement Commercial Antitrust, Competition and Trade
sectors
Life Sciences & Healthcare Consumer Products

Insights by Volodymyr

See all Insights
Legal Update Ukraine

Ukraine moves forward with MDR and IVDR implementation

14 Jul 2026 4 min read
Legal Update Ukraine

Ukraine moves to implement National Medicines Verification System

04 Feb 2026 7 min read
Legal Update Ukraine

Ukraine signs long-awaited overhaul of veterinary medicines legislation

22 Jan 2026 5 min read
Legal Update Ukraine

Ukraine tightens rules on pharmacy marketing services, post sale price adjustments and promotional practices for medicines

20 Jan 2026 5 min read
Back to top Back to top
You will now find all Law-Now content on CMS.law
Explore more
If you want to use third party tools, please enable personalisation cookies as part of your cookie preferences. You can change this setting at any time via the button below or in our Cookie Notice.